Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Graves

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry|January 11, 2019
Discovery of a crystalline sulforaphane analog with good solid-state stability and engagement of the Nrf2 pathway in vitro and in vivoJeffrey Boehm, Roderick Davis, Claudia E Murar, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Discovery of Isoxazole Amides as Potent and Selective SMYD3 InhibitorsDai-Shi Su, Junya Qu, Mark Schulz, et al.
Journal of Medicinal Chemistry|April 29, 2026
Design of Cyclic Vinyl Sulfones as WRN Covalent Inhibitors from Noncovalent BindersJustin A Caravella, Angela V Toms, Nikolay Sitnikov, et al.
Nature|October 12, 2012
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutationsMichael T McCabe, Heidi M Ott, Gopinath Ganji, et al.
Journal of Medicinal Chemistry|October 27, 2022
Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput ScreeningXinrong Tian, Dominic Suarez, Douglas Thomson, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2Sharad K Verma, Xinrong Tian, Louis V LaFrance, et al.
Nature Cancer|November 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B Pappalardi, Kathryn Keenan, Mark Cockerill, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Bioorganic & Medicinal Chemistry|January 11, 2019
Discovery of a crystalline sulforaphane analog with good solid-state stability and engagement of the Nrf2 pathway in vitro and in vivoJeffrey Boehm, Roderick Davis, Claudia E Murar, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Discovery of Isoxazole Amides as Potent and Selective SMYD3 InhibitorsDai-Shi Su, Junya Qu, Mark Schulz, et al.
Journal of Medicinal Chemistry|April 29, 2026
Design of Cyclic Vinyl Sulfones as WRN Covalent Inhibitors from Noncovalent BindersJustin A Caravella, Angela V Toms, Nikolay Sitnikov, et al.
Nature|October 12, 2012
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutationsMichael T McCabe, Heidi M Ott, Gopinath Ganji, et al.
Journal of Medicinal Chemistry|October 27, 2022
Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput ScreeningXinrong Tian, Dominic Suarez, Douglas Thomson, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2Sharad K Verma, Xinrong Tian, Louis V LaFrance, et al.
Nature Cancer|November 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B Pappalardi, Kathryn Keenan, Mark Cockerill, et al.
Pageof 3